𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder

✍ Scribed by Sergey Kravchick; Rivka Gal; Shmuel Cytron; Ronit Peled; Yona Weissman; Eliahu Mukamel; Rumelia Koren

Publisher
Springer Netherlands
Year
2001
Tongue
English
Weight
368 KB
Volume
7
Category
Article
ISSN
1219-4956

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant Bestatin immunotherapy in patie
Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder
✍ Henric Blomgren; Ingemar NΓ€slund; Pier-Luigi Esposti; Lise Johansen; Ove Aaskove πŸ“‚ Article πŸ“… 1987 πŸ› Springer-Verlag 🌐 English βš– 554 KB

The first clinical results of an ongoing, prospective trial to determine the value of adjuvant Bestatin immunotherapy in the management of bladder cancer are presented. Patients with nonmetastatic transitional cell carcinoma of the bladder, scheduled for full dose local radiation therapy (64 Gy), we

Mitomycin c in the treatment of metastat
Mitomycin c in the treatment of metastatic transitional cell carcinoma of urinary bladder
✍ K. Early; E. G. Elias; A. Mittelman; D. Albert; G. P. Murphy πŸ“‚ Article πŸ“… 1973 πŸ› John Wiley and Sons 🌐 English βš– 515 KB

Mitomycin C was administered t o 21 patients with metastatic transitional cell carcinoma of the urinary bladder. O f these, 19 patients were evaluable. Objective response occurred in f o u r patients, or 21 %. Hemopoietic depression was common and was dose related. Nephrotoxicity related t o the dr

Evaluation of the immunocompetence of pa
Evaluation of the immunocompetence of patients with transitional cell carcinoma of the bladder
✍ Adolphs, H.-D. ;Steffens, L. πŸ“‚ Article πŸ“… 1977 πŸ› Springer 🌐 English βš– 411 KB

The cellular immunocompetence was examined by means of the quantitative DNCB hypersensitivity reaction in 152 patients with transitional cell carcinomas of the bladder of Broders grades 1-4. Against a control group of 367 normal controls of both sexes, 85 patients with transitional cell carcinomas o